Amgen

Amgen bond offering to help fund Horizon Therapeutics acquisition
Seeking Alpha
Thu, 02/16/23 - 11:26 am
Amgen
bond
M&A
Horizon Therapeutics
BioSpace Layoff Tracker 2023: Grifols, Frequency, Eliem and More Cut Staff
BioSpace
Thu, 02/16/23 - 11:18 am
layoffs
Grifols
Frequency Therapeutics
Eliem Therapeutics
Aligos Therapeutics
Thermo Fisher Scientific
Magenta Therapeutics
Eisai
Amgen
Y-mAbs Therapeutics
Century Therapeutics
Elevation Oncology
Calithera Biosciences
Editas Medicine
Verily
Abzena
Layoffs continue to batter biotech, with Big Pharmas piling on the pain
Fierce Biotech
Wed, 02/1/23 - 10:32 pm
layoffs
Amgen
Merck KGaA
TCR2 Therapeutics
Moderna Therapeutics
Amgen Adopts A Two-Price Strategy For The U.S.’s First Marketed Humira-Referenced Biosimilar, Amjevita
Forbes
Wed, 02/1/23 - 10:41 am
Amgen
Amjevita
AbbVie
Humira
biosimilars
drug pricing
Amgen launches Humira biosimilar, releases Q4 earnings report
Medical Marketing and Media
Tue, 01/31/23 - 11:21 pm
Amgen
Humira
biosimilars
earnings
AbbVie
Amjevita
Humira biosimilars arrive in the US, as Amgen launches first copycat to AbbVie’s blockbuster drug
BioPharma Dive
Tue, 01/31/23 - 12:37 pm
AbbVie
Humira
biosimilars
Amgen
Amgen commits $8m to improve clinical trial diversity
Outsourcing Pharma
Tue, 01/31/23 - 10:24 am
Amgen
clinical trials
clinical trial diversity
Bristol Myers Squibb
Winn Award
Amgen, navigating 'industry headwinds,' puts 300 commercial jobs on chopping block
Fierce Pharma
Mon, 01/30/23 - 10:54 am
Amgen
layoffs
Warren keeps pressure on pharma, this time targeting Amgen and Indivior buyouts
Fierce Pharma
Mon, 01/30/23 - 10:41 am
Elizabeth Warren
Senate
FTC
M&A
Amgen
Horizon Therapeutics
Indivior
Opiant Pharmaceuticals
Amgen extends autoimmune pact with small Michigan biotech
Endpoints
Wed, 01/18/23 - 11:02 pm
Amgen
autoimmune disease
Evoq Therapeutics
Amgen prepped to take first slice of AbbVie’s US Humira pie
BioProcess International
Wed, 01/18/23 - 11:00 pm
Amgen
Humira
biosimilars
adalimumab
Amjevita
NewAmsterdam's Amgen castoff cuts LDL cholesterol in phase 2, opening new front in race to market
Fierce Biotech
Tue, 01/17/23 - 10:32 am
NewAmsterdam Pharma
Amgen
CETP inhibitors
obicetrapib
clinical trials
Big caps bounce back for biopharma
EP Vantage
Mon, 01/16/23 - 11:14 am
pharma stocks
Amgen
BeiGene
Bristol Myers Squibb
Gilead Sciences
Lantheus Holdings
Madrigal Pharmaceuticals
Merck
Moderna Therapeutics
Novo Nordisk
Prometheus Biosciences
Roche
Biopharma’s bolt-on bonanza is set to continue
EP Vantage
Thu, 01/12/23 - 10:18 am
M&A
Amgen
AstraZeneca
Bristol Myers Squibb
GSK
Ipsen
Merck
Pfizer
Amgen Boasts Lucrative Acquisitions, Drug Updates, Burgeoning Biosimilars at JPM
BioSpace
Tue, 01/10/23 - 06:43 pm
Amgen
JPMHC 2023
M&A
biosimilars
Amgen piles $2B more into pharma's ADC rush in Synaffix pact
Fierce Biotech
Thu, 01/5/23 - 04:42 pm
Amgen
antibody-drug conjugate
Synaffix
Amgen files brief to Supreme Court ahead of oral arguments — with industry amicus support
Endpoints
Tue, 01/3/23 - 10:24 pm
Amgen
Sanofi
Regeneron
Supreme Court
legal
innovation
patents
Repatha
Praluent
ADC deals: Mersana engages with Merck, LegoChem and Amgen collaborate
Biopharma Reporter
Mon, 01/2/23 - 06:41 pm
antibody-drug conjugate
Merck
LegoChem Biosciences
Mersana
Amgen
GSK
Janssen
Billionaire John Paulson Stands To Make $500 Million From Horizon’s Sale To Amgen
Forbes
Wed, 12/14/22 - 07:22 pm
Amgen
M&A
Horizon Therapeutics
John Paulson
Biopharma’s 5 Biggest M&A Deals of 2022
BioSpace
Wed, 12/14/22 - 10:50 am
M&A
Amgen
Horizon Therapeutics
Pfizer
Biohaven
Global Blood Therapeutics
Bristol Myers Squibb
Turning Point Therapeutics
ChemoCentryx

Pages